|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：L397650 |
| 產(chǎn)品名稱：LG 100268 |
| 產(chǎn)品CAS：153559-76-3 |
| 規(guī)格含量：2mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
L397650 |
| 名稱: |
LG 100268 |
| 別名: |
6-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)cyclopropyl]-3-Pyridinecarboxylic Acid; AGN 192620; ALRT 268; CD 3127; LG 268; LGD 100268; LGD 1268; |
| CAS號(hào): |
153559-76-3 |
| 分子式: |
C??H??NO? |
| 外觀: |
白色固體 |
| 熔點(diǎn): |
276-278ºC (dec.) |
| 分子量: |
363.49 |
| 儲(chǔ)存: |
-20°C Freezer |
| 溶解度: |
Chloroform (Slightly), Methanol (Slightly) |
| 種類: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
LG 100268 is a potent RXR agonist for evaluation in the treatment of non-insulin-dependent (type II) diabetes mellitus (NIDDM). |
| 參考文獻(xiàn) |
|
|
|
|
?您的位置：
